Cited by 306SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 epidemiological studies

Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands

Open access
Oude Munnink, Bas B., Nieuwenhuijse, David F., Stein, Mart, O’Toole, Áine, Haverkate, Manon, Mollers, Madelief, Kamga, Sandra K., Schapendonk, Claudia +80 more·2020·Nature Medicine

Abstract

In late December 2019, a cluster of cases of pneumonia of unknown etiology were reported linked to a market in Wuhan, China 1. The causative agent was identified as the species Severe acute respiratory syndrome-related coronavirus and was named SARS-CoV-2 (ref. 2). By 16 April the virus had spread to 185 different countries, infected over 2,000,000 people and resulted in over 130,000 deaths 3. In the Netherlands, the first case of SARS-CoV-2 was notified on 27 February. The outbreak started with several different introductory events from Italy, Austria, Germany and France followed by local amplification in, and later also outside, the south of the Netherlands. The combination of near to real-time whole-genome sequence analysis and epidemiology resulted in reliable assessments of the extent of SARS-CoV-2 transmission in the community, facilitating early decision-making to control local transmission of SARS-CoV-2 in the Netherlands. We demonstrate how these data were generated and analyzed, and how SARS-CoV-2 whole-genome sequencing, in combination with epidemiological data, was used to inform public health decision-making in the Netherlands.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-020-0997-y

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Viral genetic diversity, evolution, variable infectivity, or co-pathogenesis might contribute to infectivity and fatality but not much to COVID-19 disease heterogeneity.

    “Numerous mutations identified so far by thousands of viral sequences obtained during the first 9 months of the pandemic (Candido et al., 2020; Oude Munnink et al., 2020) suggest that viral genetic diversity, genetic evolution, variable infectivity, or co-pathogenesis might contribute to infectivity and fatality, but not so much to disease heterogeneity observed for COVID-19.”

    From COVID-19 and the human innate immune system (2021) · cites this paper as Oude Munnink et al., 2020

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 35 · Cited by 306

Authors
Oude Munnink, B. B., Nieuwenhuijse, D. F., Stein, M., O’Toole, Á., Haverkate, M., Mollers, M., Kamga, S. K., Schapendonk, C., Pronk, M., Lexmond, P., van der Linden, A., Bestebroer, T., Chestakova, I., Overmars, R. J., van Nieuwkoop, S., Molenkamp, R., van der Eijk, A. A., GeurtsvanKessel, C., Vennema, H., Meijer, A., Rambaut, A., van Dissel, J., Sikkema, R. S., Timen, A., Koopmans, M., The Dutch-Covid-19 response team, Oudehuis, G. J. A. P. M., Schinkel, J., Kluytmans, J., Kluytmans-van den Bergh, M., van den Bijllaardt, W., Berntvelsen, R. G., van Rijen, M. M. L., Schneeberger, P., Pas, S., Diederen, B. M., Bergmans, A. M. C., van der Eijk, P. A. V., Verweij, J. J., Buiting, A. G. N., Streefkerk, R., Aldenkamp, A. P., de Man, P., Koelemal, J. G. M., Ong, D., Paltansing, S., Veassen, N., Sleven, J., Bakker, L., Brockhoff, H., Rietveld, A., Slijkerman Megelink, F., Cohen Stuart, J., de Vries, A., van der Reijden, W., Ros, A., Lodder, E., Verspui-van der Eijk, E., Huijskens, I., Kraan, E. M., van der Linden, M. P. M., Debast, S. B., Naiemi, N. A., Kroes, A. C. M., Damen, M., Dinant, S., Lekkerkerk, S., Pontesilli, O., Smit, P., van Tienen, C., Godschalk, P. C. R., van Pelt, J., Ott, A., van der Weijden, C., Wertheim, H., Rahamat-Langendoen, J., Reimerink, J., Bodewes, R., Duizer, E., van der Veer, B., Reusken, C., Lutgens, S., Schneeberger, P., Hermans, M., Wever, P., Leenders, A., ter Waarbeek, H., & Hoebe, C.
Affiliations
  • Erasmus MC (NL)
  • National Institute for Public Health and the Environment (NL)
  • University of Edinburgh (GB)
  • Maastricht University Medical Centre (NL)
  • Amphia Ziekenhuis (NL)
  • Dienst Gezondheid & Jeugd (NL)
  • Ziekenhuis Bernhoven (NL)
  • PAMM (NL)
  • Sint Franciscus Gasthuis (NL)
  • Regio Gooi en Vechtstreek (NL)
  • Stichting Haaglanden Medisch Centrum (NL)
  • GGD Hart voor Brabant (NL)
  • IJsselland Ziekenhuis (NL)
  • Isala (NL)
  • Leiden University Medical Center (NL)
  • Maasstad Ziekenhuis (NL)
  • Meander Medisch Centrum (NL)
  • Radboud University Medical Center (NL)
  • Jeroen Bosch Ziekenhuis (NL)
Corresponding author
Koopmans, Marion
Venue
Nature Medicine
Published
2020-07-16
Volume
26
Issue
9
Pages
1405-1410
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W3043746245
Cited by
306
References
35
Citations by year
2026: 9 · 2025: 14 · 2024: 21 · 2023: 33 · 2022: 73 · 2021: 122 · 2020: 34
FWCI
8.58
Type
journal article
Language
en
Open access
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, other-oa)
  • Pure Amsterdam UMC (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Rivm Repository (Netherlands National Institute for Public Health and the Environment) (submittedVersion)
  • Rivm (National Institute for Public Health and the Environment) (submittedVersion)
  • Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
  • Rivm (National Institute for Public Health and the Environment) (submittedVersion, other-oa)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
  • EC | Horizon 2020 Framework Programme (874735, 848096, 101003589)
  • European Joint Programme One Health EJP under the grant agreement
  • U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201400008C)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
  • Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
Keywords
SARS-CoV-2, COVID-19 pandemic, whole genome sequencing, public health decision-making, epidemic control, Netherlands, community transmission
MeSH terms
Clinical Decision-Making, Whole Genome Sequencing, Betacoronavirus, COVID-19, SARS-CoV-2, Humans, Netherlands, Pneumonia, Viral, Public Health, Genome, Viral, Coronavirus Infections, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review